LAUREANA, ROBERTA
 Distribuzione geografica
Continente #
AS - Asia 244
NA - Nord America 243
EU - Europa 112
SA - Sud America 59
AF - Africa 4
Totale 662
Nazione #
US - Stati Uniti d'America 225
SG - Singapore 130
IT - Italia 51
BR - Brasile 49
CN - Cina 39
HK - Hong Kong 36
VN - Vietnam 15
CA - Canada 12
RU - Federazione Russa 10
DE - Germania 9
GB - Regno Unito 9
IN - India 7
PL - Polonia 7
ES - Italia 6
FI - Finlandia 6
UY - Uruguay 6
MX - Messico 5
NL - Olanda 5
JP - Giappone 4
BD - Bangladesh 3
ID - Indonesia 3
SE - Svezia 3
TR - Turchia 3
AT - Austria 2
PY - Paraguay 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CH - Svizzera 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
FR - Francia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
LT - Lituania 1
PK - Pakistan 1
Totale 662
Città #
Singapore 70
Hong Kong 36
Ashburn 31
Beijing 26
The Dalles 20
Rome 18
Dallas 15
Los Angeles 14
Santa Clara 11
Del Norte 9
Ho Chi Minh City 9
New York 7
Montevideo 6
São Paulo 6
Warsaw 6
Buffalo 5
Montreal 5
Phoenix 5
Chicago 4
Council Bluffs 4
Hanoi 4
Houston 4
Lappeenranta 4
Mexico City 4
Munich 4
Orem 4
Redondo Beach 4
Tokyo 4
Chennai 3
Denver 3
Monte Vista 3
Poplar 3
Stockholm 3
Toronto 3
Albinea 2
Asunción 2
Atlanta 2
Bari 2
Belo Horizonte 2
Boardman 2
Brooklyn 2
Campo Grande 2
Curitiba 2
Goiânia 2
London 2
Milan 2
Mogi Guaçu 2
San Francisco 2
Seattle 2
Trieste 2
Valencia 2
Vancouver 2
Al ‘Arīsh 1
Amandola 1
Ankara 1
Aracaju 1
Baie-D'Urfé 1
Barra Mansa 1
Bolzano 1
Boston 1
Brasília 1
Camaçari 1
Caxias do Sul 1
City of London 1
Columbus 1
Compton 1
DeLand 1
Dhaka 1
Dom Eliseu 1
Elk Grove Village 1
Filadélfia 1
Frankfurt am Main 1
Gravataí 1
Guanhães 1
Helena 1
Helsinki 1
Hyderabad 1
Istanbul 1
Itabaiana 1
Itatira 1
Izhevsk 1
Jacksonville 1
Jakarta 1
Johannesburg 1
Juneau 1
Karachi 1
Kostroma 1
Lajeado 1
Limoeiro 1
Maicao 1
Malappuram 1
McDonough 1
Moscow 1
Mumbai 1
Nairobi 1
Norfolk 1
North Bergen 1
Nova Petrópolis 1
Orlando 1
Osasco 1
Totale 441
Nome #
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study 100
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia 60
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 58
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 58
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia 55
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: a retrospective real-life multicenter Italian cohort 54
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 52
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients 50
Association of [18F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia 50
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens 40
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 38
Outcome dei pazienti affetti da Leucemia Linfatica Cronica trattati con ibrutinib a dosaggio ridotto: studio di real life 37
Familial Forms of Chronic Lymphocytic Leukemia Have a Worse Prognosis Than Sporadic Forms: an Italian Case-Control Study 35
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience 31
Totale 718
Categoria #
all - tutte 2.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 3 0 0 0 2 2 1 0 2 5
2024/2025281 30 44 23 6 5 20 16 10 14 27 40 46
2025/2026422 70 47 68 110 93 34 0 0 0 0 0 0
Totale 718